ZeroStack Corp.

ZSTK · NasdaqCM · Stock · Financial Services

$4.01

-8.24% today

Delayed price, 2026-10-14 17:51 UTC

What ZeroStack does

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

Key facts

Sector

Financial Services

Industry

Asset Management

Market cap

$87.4M

P/E (ttm)

—

Forward P/E

—

Dividend yield

0.00%

Beta

1.93

Profit margin

0.0%

Employees

Headquarters

Toronto, ON, Canada

Exchange

NasdaqCM

Website

zerostack.ai

Performance

1 Month

-14.9%

3 Months

+135.9%

6 Months

-46.6%

1 Year

-77.7%

5 Years

-99.7%

$1.3252-week range$20.45

Biggest setback — last 12 months

-91.9%

13 Oct 2025 → 20 Jul 2026

Fell from $18.00 to $1.45 — its sharpest sustained decline this year.

Biggest run-up — last 12 months

+273.1%

20 Jul 2026 → 24 Aug 2026

Ran from $1.45 to $5.41 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend

Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.

Horizon	Bear case (−1σ)	Base case	Bull case (+1σ)
1 Month	$2.60 (-35.1%)	$4.01	$6.18 (+54.2%)
3 Months	$1.89 (-52.8%)	$4.01	$8.49 (+111.7%)
6 Months	$1.39 (-65.4%)	$4.01	$11.58 (+188.8%)
12 Months	$0.89 (-77.7%)	$4.01	$17.97 (+348.2%)

Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 150.0%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

ACH

Accendra Health, Inc.

$0.29 · -9.2%

EXHI

Exlites Holdings International, Inc.

PD-Rx Pharmaceuticals, Inc.

Acro Biomedical Co., Ltd.

$0.03 · +0.0%

Recent insider activity

Sold 1,000 shares at $7.57 — Rong Rudy, President · 2026-08-21

Acquired 4,608,575 shares at $0.75 — Heinrich Michael, Executive Chairman · 2026-07-20

Acquired 5,954,743 shares — Reis-Faria Daniel, CEO · 2026-07-20

Acquired 250,000 shares — Vaiman Dany, CFO · 2026-07-20

Acquired 28,000 shares — Zeifman Laurence, Director · 2026-05-07

Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

What is a stock? Understanding risk and reward Why diversification matters

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.